Introduksjon
Denne siden gir en grundig analyse av den kjente historikken for insidernes handelsaktiviteter for Kevin F Mclaughlin. Insidere er ledere, direktører eller betydelige investorer i et selskap. Det er ulovlig for insidere å gjøre handler i deres selskaper basert på spesifikke, ikke-offentlig informasjon. Dette betyr ikke at det er ulovlig for dem å gjøre noen handler i deres egne selskaper. Imidlertid må de rapportere alle handler til SEC via et skjema 4. Til tross for disse begrensningene, antyder akademisk forskning at insidere - generelt sett - har en tendens til å overgå markedet i sine egne selskaper.
Gjennomsnittlig handelslønnsomhet
Den gjennomsnittlige handelslønnsomheten er den gjennomsnittlige avkastningen av alle åpne markedskjøp gjort av insideren de siste tre årene. For å beregne dette, undersøker vi hvert eneste åpne marked, uplanlagte kjøp som er gjort av insideren, men dette inkluderer ikke alle handler som ble markert som en del av en 10b5-1 handelsplan. Vi beregner deretter gjennomsnittlig ytelse av disse handlene over 3, 6 og 12 måneder, gjennomsnittlig hver av disse varighetene for å generere en endelig ytelsesmåling for hver handel. Til slutt,
Dersom lønnsomheten for denne interne handelen er "N/A", har enten den interne personen ikke gjort noen åpen-markeds kjøp de siste tre årene, eller så er handlene for nylig til å beregne en pålitelig prestasjonsmåler.
Oppdateringsfrekvens: Daglig
Selskaper med rapporterte insiderposisjoner
SEC-arkiveringene indikerer at Kevin F Mclaughlin har rapporterte beholdninger av handler i følgende selskaper:
Verdipapir | Navn | Siste rapporterte høydepunkter |
---|---|---|
US:VCEL / Vericel Corporation | Director | 15 100 |
US:DBTX / Decibel Therapeutics Inc | Director | 0 |
US:XLRN / Acceleron Pharma Inc | SVP, CFO and Treasurer | 0 |
Hvordan tolke diagrammene
De følgende diagrammene viser aksjens ytelse etter hver åpen markedstransaksjon som ikke var planlagt, utført av Kevin F Mclaughlin. Ikke-planlagte handler er handler som ikke ble gjort som en del av en 10b5-1 handelsplan. Aksjeytelsen er kartlagt som kumulativ prosentendring i aksjekursen. For eksempel, hvis en innsidehandel ble gjort 1. januar 2019, vil diagrammet vise daglig prosentendring for verdipapiret til dagens dato. Dersom aksjeprisen går fra $10 til $15 i løpet av denne tiden, vil den kumulative prosentendringen i aksjeprisen være 50%. En endring i prisen fra $10 til $20 vil være 100%, og en endring i prisen fra $10 til $5 vil være - 50%.
Til syvende og sist er målet vårt å avgjøre hvor tett insidernes handler korrelerer med overavkastninger (positiv eller negativ) i aksjekursen for å se om insidere timer sine handler for å tjene på intern informasjon. Se for deg en situasjon der en insider gjør dette. I denne situasjonen, forventer vi enten (a) positive avkastninger etter kjøp, eller (b) negative avkastninger etter salg. I tilfelle (a) KJØP-diagrammet ville vise en serie av oppadgående kurver, som indikerer positive avkastninger etter hver kjøpstransaksjon. I tilfelle (b) ville SALG-diagrammet vise en serie av nedadgående kurver, som indikerer negative avkastninger etter hver salgstransaksjon.
Imidlertid er dette alene ikke nok til å dra konklusjoner. Hvis, for eksempel, aksjeprisen for selskapet steg jevnt over mange år uten å følge en syklisk trend, ville vi forventet at alle postkjøpsdiagrammer skal ha en stigende trend. På samme måte vil ikke-sykliske nedganger over mange år resultere i nedadgående trend i post-trade diagrammer. Ingen av disse diagrammene ville antyde aktiviteter som insidertrening.
Den sterkeste indikatoren ville vært en situasjon der aksjekursen var ekstremt syklisk, og det var både positive signaler i KJØPSdiagrammet og negative plot i SALGSdiagrammet. Denne situasjonen ville vært sterkt antydende om en insider som timet handler til sin økonomiske fordel.
Internkjøp VCEL / Vericel Corporation - Analyse av kortsiktig fortjeneste
I denne seksjonen analyserer vi lønnsomheten av hvert uplanlagt, åpen-marked internsalg som er gjort i VCEL / Vericel Corporation. Denne analysen hjelper til å forstå om den interne personen regelmessig genererer unormale avkastninger, og er verdt å følge. Denne analysen gjelder ett år etter hver handel, og resultatene er teoretiske.
Følgende tabell viser de mest nylige åpne markedskjøpene som ikke var en del av en handelsplan.
Handelsdato | Ticker | Innsider | Rapporterte aksjer |
Rapportert pris |
Justerte aksjer |
Justert pris |
Kostpris | Dager til maks |
Pris ved maks |
Maks fortjeneste ($) |
Maks fortjeneste (%) |
---|---|---|---|---|---|---|---|
Det er ingen kjente uplanlagte handler på det åpne markedet for denne insideren og verdipapirkombinasjonen. |
Justert pris er prisen justert for splitt. Justerte aksjer er aksjene justert for splitt.
Internhandel VCEL / Vericel Corporation - Analyse av kortsiktig tap
I denne seksjonen analyserer vi unngåelsen av kortsiktig tap for hvert uplanlagt, åpen-marked internsalg som er gjort i VCEL / Vericel Corporation. Et jevnt mønster av tap unngåelse kan antyde at fremtidige salgstransaksjoner kan forutsi nedgang i pris. Denne analysen gjelder ett år etter hver handel, og resultatene er teoretiske.
Følgende tabell viser de mest nylige åpne markedskjøpene som ikke var en del av en handelsplan.
Handelsdato | Ticker | Innsider | Rapporterte aksjer |
Rapportert pris |
Justerte aksjer |
Justert pris |
Kostpris | Dager til min |
Pris ved min |
Maks tap unngått ($) |
Maks tap unngått (%) |
---|---|---|---|---|---|---|---|
Det er ingen kjente uplanlagte handler på det åpne markedet for denne insideren og verdipapirkombinasjonen. |
Justert pris er prisen justert for splitt. Justerte aksjer er aksjene justert for splitt.
Innsidernes handelshistorikk
Tabellen viser den komplette listen over innsidehandler gjort av Kevin F Mclaughlin som avslørt til Securies Exchange Comission (SEC).
Fildato | Transaksjonsdato | Skjema | Ticker | Verdipapir | Kode | Aksjer | Gjenværende aksjer | Prosent endring |
Aksje pris |
Transaksjons verdi |
Gjenværende verdi |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-08-08 |
|
4 | VCEL |
Vericel Corp
Common Stock |
S - Sale | X | −7 000 | 15 100 | −31,67 | 35,92 | −251 440 | 542 392 |
2025-08-08 |
|
4 | VCEL |
Vericel Corp
Common Stock |
M - Exercise | 7 000 | 22 100 | 46,36 | 2,76 | 19 320 | 60 996 | |
2025-05-09 |
|
4 | VCEL |
Vericel Corp
Common Stock |
S - Sale | X | −7 000 | 15 100 | −31,67 | 39,98 | −279 860 | 603 698 |
2025-05-09 |
|
4 | VCEL |
Vericel Corp
Common Stock |
M - Exercise | 7 000 | 22 100 | 46,36 | 2,76 | 19 320 | 60 996 | |
2025-05-02 |
|
4 | VCEL |
Vericel Corp
Common Stock |
M - Exercise | 3 200 | 15 100 | 26,89 | ||||
2025-02-14 |
|
4 | VCEL |
Vericel Corp
Common Stock |
S - Sale | X | −1 000 | 11 900 | −7,75 | 55,43 | −55 430 | 659 617 |
2025-02-14 |
|
4 | VCEL |
Vericel Corp
Common Stock |
M - Exercise | 1 000 | 12 900 | 8,40 | 2,76 | 2 760 | 35 604 | |
2025-02-14 |
|
4 | VCEL |
Vericel Corp
Common Stock |
S - Sale | X | −6 000 | 11 900 | −33,52 | 55,47 | −332 820 | 660 093 |
2025-02-14 |
|
4 | VCEL |
Vericel Corp
Common Stock |
M - Exercise | 6 000 | 17 900 | 50,42 | 3,74 | 22 440 | 66 946 | |
2024-11-15 |
|
4 | VCEL |
Vericel Corp
Common Stock |
S - Sale | X | −7 000 | 11 900 | −37,04 | 55,54 | −388 780 | 660 926 |
2024-11-15 |
|
4 | VCEL |
Vericel Corp
Common Stock |
M - Exercise | 7 000 | 18 900 | 58,82 | 3,74 | 26 180 | 70 686 | |
2024-08-09 |
|
4 | VCEL |
Vericel Corp
Common Stock |
S - Sale | X | −2 000 | 11 900 | −14,39 | 45,99 | −91 980 | 547 281 |
2024-08-09 |
|
4 | VCEL |
Vericel Corp
Common Stock |
M - Exercise | 2 000 | 13 900 | 16,81 | 3,74 | 7 480 | 51 986 | |
2024-08-09 |
|
4 | VCEL |
Vericel Corp
Common Stock |
S - Sale | X | −5 000 | 11 900 | −29,59 | 45,92 | −229 600 | 546 448 |
2024-08-09 |
|
4 | VCEL |
Vericel Corp
Common Stock |
M - Exercise | 5 000 | 16 900 | 42,02 | 3,74 | 18 700 | 63 206 | |
2024-05-03 |
|
4 | VCEL |
Vericel Corp
Common Stock |
M - Exercise | 3 200 | 11 900 | 36,78 | ||||
2023-09-25 |
|
4 | DBTX |
Decibel Therapeutics, Inc.
Common Stock |
D - Sale to Issuer | −5 000 | 0 | −100,00 | ||||
2023-06-14 |
|
4 | DBTX |
Decibel Therapeutics, Inc.
Common Stock |
A - Award | 5 000 | 5 000 | |||||
2023-04-28 |
|
4 | VCEL |
Vericel Corp
Common Stock |
M - Exercise | 2 600 | 8 700 | 42,62 | ||||
2022-04-29 |
|
4 | VCEL |
Vericel Corp
Restricted Stock Unit |
A - Award | 2 600 | 2 600 | |||||
2022-04-29 |
|
4 | VCEL |
Vericel Corp
Stock Option (right to buy) |
A - Award | 6 500 | 6 500 | |||||
2022-04-29 |
|
4 | VCEL |
Vericel Corp
Restricted Stock Unit |
M - Exercise | −2 600 | 0 | −100,00 | ||||
2022-04-29 |
|
4 | VCEL |
Vericel Corp
Common Stock |
M - Exercise | 2 600 | 6 100 | 74,29 | ||||
2021-11-22 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
D - Sale to Issuer | −18 806 | 0 | −100,00 | ||||
2021-11-22 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
D - Sale to Issuer | −24 334 | 0 | −100,00 | ||||
2021-11-22 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
D - Sale to Issuer | −20 500 | 0 | −100,00 | ||||
2021-11-22 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
D - Sale to Issuer | −11 262 | 0 | −100,00 | ||||
2021-11-22 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
D - Sale to Issuer | −2 663 | 0 | −100,00 | ||||
2021-11-22 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
U - Other | −10 681 | 0 | −100,00 | ||||
2021-09-24 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −170 | 20 500 | −0,82 | |||
2021-09-24 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −5 200 | 11 262 | −31,59 | |||
2021-09-24 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −5 370 | 10 681 | −33,46 | 160,38 | −861 241 | 1 713 019 |
2021-09-24 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 170 | 16 051 | 1,07 | 41,64 | 7 079 | 668 364 |
2021-09-24 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 5 200 | 15 881 | 48,68 | 40,61 | 211 172 | 644 927 |
2021-09-24 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −7 330 | 20 670 | −26,18 | |||
2021-09-24 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −9 800 | 16 462 | −37,32 | |||
2021-09-24 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −2 500 | 2 663 | −48,42 | |||
2021-09-24 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −983 | 10 681 | −8,43 | 161,26 | −158 519 | 1 722 418 |
2021-09-24 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −18 647 | 11 664 | −61,52 | 160,26 | −2 988 368 | 1 869 273 |
2021-09-24 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 7 330 | 30 311 | 31,90 | 41,64 | 305 221 | 1 262 150 |
2021-09-24 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 9 800 | 22 981 | 74,35 | 40,61 | 397 978 | 933 258 |
2021-09-24 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 2 500 | 13 181 | 23,41 | 30,17 | 75 425 | 397 671 |
2021-04-30 |
|
4 | VCEL |
Vericel Corp
Restricted Stock Unit |
A - Award | 2 600 | 2 600 | |||||
2021-04-30 |
|
4 | VCEL |
Vericel Corp
Stock Option (right to buy) |
A - Award | 6 500 | 6 500 | |||||
2021-04-30 |
|
4 | VCEL |
Vericel Corp
Restricted Stock Unit |
M - Exercise | −1 750 | 0 | −100,00 | ||||
2021-04-30 |
|
4 | VCEL |
Vericel Corp
Common Stock |
M - Exercise | 1 750 | 3 500 | 100,00 | ||||
2021-02-02 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
A - Award | 18 806 | 18 806 | |||||
2021-02-02 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
A - Award | 4 868 | 10 681 | 83,74 | ||||
2021-01-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −4 | 5 813 | −0,07 | 123,50 | −494 | 717 906 |
2021-01-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −296 | 5 817 | −4,84 | 122,85 | −36 364 | 714 618 |
2021-01-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −499 | 6 113 | −7,55 | 121,89 | −60 823 | 745 114 |
2021-01-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −700 | 6 612 | −9,57 | 120,43 | −84 301 | 796 283 |
2021-01-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −300 | 7 312 | −3,94 | 124,45 | −37 335 | 909 978 |
2021-01-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −667 | 7 612 | −8,06 | 124,47 | −83 021 | 947 466 |
2021-01-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −600 | 8 279 | −6,76 | 123,49 | −74 094 | 1 022 374 |
2021-01-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −200 | 8 879 | −2,20 | 125,49 | −25 098 | 1 114 226 |
2021-01-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −713 | 9 079 | −7,28 | 124,28 | −88 612 | 1 128 338 |
2021-01-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −800 | 9 792 | −7,55 | 123,54 | −98 832 | 1 209 704 |
2021-01-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
F - Taxes | −624 | 10 592 | −5,56 | 124,31 | −77 569 | 1 316 692 | |
2020-12-15 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −2 590 | 26 262 | −8,98 | |||
2020-12-15 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −24 986 | 5 163 | −82,88 | |||
2020-12-15 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −7 700 | 0 | −100,00 | |||
2020-12-15 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −7 252 | 0 | −100,00 | |||
2020-12-15 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −42 528 | 11 216 | −79,13 | 130,14 | −5 534 594 | 1 459 650 |
2020-12-15 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 2 590 | 53 744 | 5,06 | 40,61 | 105 180 | 2 182 544 |
2020-12-15 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 24 986 | 51 154 | 95,48 | 30,17 | 753 828 | 1 543 316 |
2020-12-15 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 7 700 | 26 168 | 41,69 | 27,97 | 215 369 | 731 919 |
2020-12-15 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 7 252 | 18 468 | 64,66 | 41,20 | 298 782 | 760 882 |
2020-12-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −3 100 | 7 252 | −29,95 | |||
2020-12-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −3 100 | 11 216 | −21,65 | 125,00 | −387 500 | 1 402 000 |
2020-12-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 3 100 | 14 316 | 27,64 | 41,20 | 127 720 | 589 819 |
2020-12-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −100 | 28 852 | −0,35 | |||
2020-12-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −100 | 28 852 | −0,35 | |||
2020-12-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −100 | 30 149 | −0,33 | |||
2020-12-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −200 | 7 700 | −2,53 | |||
2020-12-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −500 | 11 216 | −4,27 | 125,12 | −62 560 | 1 403 346 |
2020-12-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 100 | 11 716 | 0,86 | 40,61 | 4 061 | 475 787 |
2020-12-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 100 | 11 616 | 0,87 | 30,17 | 3 017 | 350 455 |
2020-12-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 200 | 11 516 | 1,77 | 27,97 | 5 594 | 322 103 |
2020-12-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 100 | 11 316 | 0,89 | 41,20 | 4 120 | 466 219 |
2020-12-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −1 873 | 28 952 | −6,08 | |||
2020-12-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −1 051 | 30 249 | −3,36 | |||
2020-12-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −400 | 7 900 | −4,82 | |||
2020-12-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −548 | 10 452 | −4,98 | |||
2020-12-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −3 872 | 11 216 | −25,66 | 125,03 | −484 116 | 1 402 336 |
2020-12-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 1 873 | 15 088 | 14,17 | 40,61 | 76 063 | 612 724 |
2020-12-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 1 051 | 13 215 | 8,64 | 30,17 | 31 709 | 398 697 |
2020-12-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 400 | 12 164 | 3,40 | 27,97 | 11 188 | 340 227 |
2020-12-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 548 | 11 764 | 4,89 | 41,20 | 22 578 | 484 677 |
2020-05-01 |
|
4 | VCEL |
Vericel Corp
Restricted Stock Unit |
A - Award | 1 750 | 1 750 | |||||
2020-05-01 |
|
4 | VCEL |
Vericel Corp
Stock Option (right to buy) |
A - Award | 13 125 | 13 125 | |||||
2020-05-01 |
|
4 | VCEL |
Vericel Corp
Restricted Stock Unit |
M - Exercise | −1 750 | 0 | −100,00 | 14,56 | −25 480 | ||
2020-05-01 |
|
4 | VCEL |
Vericel Corp
Common Stock |
M - Exercise | 1 750 | 1 750 | |||||
2020-04-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −17 226 | 11 000 | −61,03 | |||
2020-04-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −17 226 | 11 216 | −60,57 | 88,19 | −1 519 161 | 989 139 |
2020-04-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 17 226 | 28 442 | 153,58 | 41,20 | 709 711 | 1 171 810 |
2020-04-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −10 000 | 31 300 | −24,21 | |||
2020-04-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −10 000 | 31 300 | −24,21 | |||
2020-04-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −12 774 | 28 226 | −31,16 | |||
2020-04-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −4 000 | 0 | −100,00 | |||
2020-04-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −3 703 | 11 216 | −24,82 | 87,50 | −324 012 | 981 400 |
2020-04-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −5 921 | 14 919 | −28,41 | 86,79 | −513 884 | 1 294 820 |
2020-04-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −15 410 | 20 840 | −42,51 | 85,80 | −1 322 178 | 1 788 072 |
2020-04-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −3 803 | 36 250 | −9,49 | 84,89 | −322 837 | 3 077 262 |
2020-04-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −5 037 | 40 053 | −11,17 | 83,68 | −421 496 | 3 351 635 |
2020-04-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −2 900 | 45 090 | −6,04 | 82,83 | −240 207 | 3 734 805 |
2020-04-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 10 000 | 47 990 | 26,32 | 30,17 | 301 700 | 1 447 858 |
2020-04-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 10 000 | 37 990 | 35,73 | 27,97 | 279 700 | 1 062 580 |
2020-04-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 12 774 | 27 990 | 83,95 | 41,20 | 526 289 | 1 153 188 |
2020-04-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 4 000 | 15 216 | 35,66 | 24,11 | 96 440 | 366 858 |
2020-01-24 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
A - Award | 24 334 | 24 334 | |||||
2020-01-24 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
A - Award | 6 369 | 11 216 | 131,40 | ||||
2020-01-03 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −1 566 | 4 847 | −24,42 | 52,52 | −82 246 | 254 564 |
2020-01-03 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −2 300 | 6 413 | −26,40 | 52,49 | −120 727 | 336 618 |
2020-01-03 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −1 713 | 8 713 | −16,43 | 52,51 | −89 950 | 457 520 |
2019-12-17 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −11 853 | 10 426 | −53,20 | 50,28 | −595 969 | 524 219 |
2019-09-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −173 | 22 279 | −0,77 | 45,75 | −7 915 | 1 019 264 |
2019-09-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −7 827 | 22 452 | −25,85 | 45,29 | −354 485 | 1 016 851 |
2019-05-03 |
|
4 | VCEL |
Vericel Corp
Restricted Stock Unit |
A - Award | 1 750 | 1 750 | |||||
2019-05-03 |
|
4 | VCEL |
Vericel Corp
Stock Option (right to buy) |
A - Award | 13 125 | 13 125 | |||||
2019-04-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −100 | 30 279 | −0,33 | 45,46 | −4 546 | 1 376 483 |
2019-04-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −11 900 | 30 379 | −28,15 | 44,61 | −530 859 | 1 355 207 |
2019-04-04 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −648 | 42 279 | −1,51 | 48,02 | −31 117 | 2 030 238 |
2019-01-29 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
A - Award | 28 000 | 28 000 | |||||
2019-01-29 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
A - Award | 4 700 | 42 927 | 12,29 | ||||
2019-01-04 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −97 | 38 227 | −0,25 | 44,06 | −4 274 | 1 684 282 |
2019-01-04 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −1 717 | 38 324 | −4,29 | 43,33 | −74 398 | 1 660 579 |
2019-01-04 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −2 186 | 40 041 | −5,18 | 42,56 | −93 036 | 1 704 145 |
2019-01-04 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −300 | 42 227 | −0,71 | 43,20 | −12 960 | 1 824 206 |
2019-01-04 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −1 412 | 42 527 | −3,21 | 42,37 | −59 826 | 1 801 869 |
2018-08-31 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −12 500 | 18 300 | −40,58 | |||
2018-08-31 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −12 500 | 43 939 | −22,15 | 54,00 | −675 000 | 2 372 706 |
2018-08-31 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 12 500 | 56 439 | 28,45 | 27,97 | 349 625 | 1 578 599 |
2018-07-03 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −25 000 | 4 000 | −86,21 | |||
2018-07-03 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −12 500 | 43 939 | −22,15 | 49,00 | −612 500 | 2 153 011 |
2018-07-03 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −12 500 | 56 439 | −18,13 | 47,00 | −587 500 | 2 652 633 |
2018-07-03 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 25 000 | 68 939 | 56,90 | 24,11 | 602 750 | 1 662 119 |
2018-05-03 |
|
4 | VCEL |
Vericel Corp
Stock Option (right to buy) |
A - Award | 17 500 | 17 500 | |||||
2018-04-04 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −800 | 43 939 | −1,79 | 39,00 | −31 200 | 1 713 621 |
2018-04-04 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −3 200 | 44 739 | −6,68 | 38,31 | −122 592 | 1 713 951 |
2018-03-05 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
A - Award | 30 825 | 30 825 | |||||
2018-03-05 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
A - Award | 5 138 | 47 939 | 12,00 | ||||
2018-01-04 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −200 | 42 801 | −0,47 | 43,84 | −8 768 | 1 876 396 |
2018-01-04 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −14 800 | 43 001 | −25,61 | 43,00 | −636 400 | 1 849 043 |
2018-01-04 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | −6 250 | 0 | −100,00 | ||||
2018-01-04 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | −6 251 | 0 | −100,00 | ||||
2018-01-04 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | 6 250 | 57 801 | 12,12 | 5,28 | 33 000 | 305 189 | |
2018-01-04 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | 6 251 | 51 551 | 13,80 | 3,88 | 24 254 | 200 018 | |
2018-01-04 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −4 000 | 45 300 | −8,11 | 42,42 | −169 680 | 1 921 626 |
2017-09-14 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −210 | 49 300 | −0,42 | 39,85 | −8 368 | 1 964 605 |
2017-09-14 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −1 300 | 49 510 | −2,56 | 39,17 | −50 921 | 1 939 307 |
2017-09-14 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −14 490 | 50 810 | −22,19 | 38,32 | −555 257 | 1 947 039 |
2017-07-07 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −18 750 | 0 | −100,00 | |||
2017-07-07 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −3 150 | 6 250 | −33,51 | |||
2017-07-07 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −34 400 | 65 300 | −34,50 | 32,00 | −1 100 800 | 2 089 600 |
2017-07-07 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 18 750 | 99 700 | 23,16 | 7,12 | 133 500 | 709 864 |
2017-07-07 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 3 150 | 80 950 | 4,05 | 5,28 | 16 632 | 427 416 |
2017-05-05 |
|
4 | VCEL |
Vericel Corp
Stock Option (right to buy) |
A - Award | 17 500 | 17 500 | |||||
2017-03-14 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
A - Award | 41 300 | 41 300 | |||||
2017-03-14 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
A - Award | 6 900 | 77 800 | 9,73 | ||||
2017-01-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −1 300 | 70 900 | −1,80 | 27,63 | −35 919 | 1 958 967 |
2017-01-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −400 | 72 200 | −0,55 | 26,87 | −10 748 | 1 940 014 |
2017-01-04 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | −10 000 | 6 251 | −61,53 | ||||
2017-01-04 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | 10 000 | 72 600 | 15,97 | 3,88 | 38 800 | 281 688 | |
2016-07-07 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | −5 000 | 16 251 | −23,53 | ||||
2016-07-07 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | 5 000 | 62 600 | 8,68 | 3,88 | 19 400 | 242 888 | |
2016-07-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −15 300 | 9 400 | −61,94 | |||
2016-07-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −25 300 | 57 600 | −30,52 | 34,66 | −876 898 | 1 996 416 |
2016-07-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 15 300 | 82 900 | 22,63 | 5,28 | 80 784 | 437 712 |
2016-05-25 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −300 | 24 700 | −1,20 | |||
2016-05-25 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −25 300 | 67 600 | −27,23 | 34,00 | −860 200 | 2 298 400 |
2016-05-25 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 300 | 92 900 | 0,32 | 5,28 | 1 584 | 490 512 |
2016-05-06 |
|
4 | VCEL |
Vericel Corp
Stock Option (right to buy) |
A - Award | 15 000 | 15 000 | |||||
2016-03-07 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
A - Award | 30 800 | 30 800 | |||||
2016-03-07 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
A - Award | 5 100 | 92 600 | 5,83 | ||||
2015-12-23 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | −7 500 | 21 251 | −26,09 | ||||
2015-12-23 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | 7 500 | 87 500 | 9,38 | 3,88 | 29 100 | 339 500 | |
2015-10-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −7 000 | 28 751 | −19,58 | |||
2015-10-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −3 460 | 80 000 | −4,15 | 24,64 | −85 254 | 1 971 200 |
2015-10-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −3 540 | 83 460 | −4,07 | 24,12 | −85 385 | 2 013 055 |
2015-10-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 7 000 | 87 000 | 8,75 | 3,88 | 27 160 | 337 560 |
2015-09-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
A - Award | 40 000 | 80 000 | 100,00 | ||||
2015-09-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −1 500 | 35 751 | −4,03 | |||
2015-09-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −5 000 | 37 251 | −11,83 | |||
2015-09-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −176 | 40 000 | −0,44 | 31,16 | −5 484 | 1 246 400 |
2015-09-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −724 | 40 176 | −1,77 | 30,45 | −22 046 | 1 223 359 |
2015-09-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −600 | 40 900 | −1,45 | 29,39 | −17 634 | 1 202 051 |
2015-09-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 1 500 | 41 500 | 3,75 | 3,88 | 5 820 | 161 020 |
2015-09-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −1 293 | 40 000 | −3,13 | 31,07 | −40 174 | 1 242 800 |
2015-09-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −2 500 | 41 293 | −5,71 | 30,22 | −75 550 | 1 247 874 |
2015-09-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −1 207 | 43 793 | −2,68 | 29,11 | −35 136 | 1 274 814 |
2015-09-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 5 000 | 45 000 | 12,50 | 3,88 | 19 400 | 174 600 |
2015-08-12 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −1 500 | 42 251 | −3,43 | |||
2015-08-12 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −5 000 | 43 751 | −10,26 | |||
2015-08-12 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −1 500 | 40 000 | −3,61 | 28,54 | −42 810 | 1 141 600 |
2015-08-12 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 1 500 | 41 500 | 3,75 | 3,88 | 5 820 | 161 020 |
2015-08-12 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −100 | 40 000 | −0,25 | 29,23 | −2 923 | 1 169 200 |
2015-08-12 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −4 900 | 40 100 | −10,89 | 28,51 | −139 699 | 1 143 251 |
2015-08-12 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 5 000 | 45 000 | 12,50 | 3,88 | 19 400 | 174 600 |
2015-07-30 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | −5 000 | 48 751 | −9,30 | ||||
2015-07-30 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | 5 000 | 40 000 | 14,29 | 3,88 | 19 400 | 155 200 | |
2015-07-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −2 000 | 53 751 | −3,59 | |||
2015-07-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −5 000 | 55 751 | −8,23 | |||
2015-07-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −95 | 35 000 | −0,27 | 30,39 | −2 887 | 1 063 650 |
2015-07-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −1 905 | 35 095 | −5,15 | 29,68 | −56 540 | 1 041 620 |
2015-07-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 2 000 | 37 000 | 5,71 | 3,88 | 7 760 | 143 560 |
2015-07-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −377 | 35 000 | −1,07 | 30,27 | −11 412 | 1 059 450 |
2015-07-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −4 623 | 35 377 | −11,56 | 29,65 | −137 072 | 1 048 928 |
2015-07-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 5 000 | 40 000 | 14,29 | 3,88 | 19 400 | 155 200 |
2015-06-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | −5 000 | 60 751 | −7,60 | ||||
2015-06-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | 5 000 | 35 000 | 16,67 | 3,88 | 19 400 | 135 800 | |
2015-06-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −1 500 | 65 751 | −2,23 | |||
2015-06-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −5 000 | 67 251 | −6,92 | |||
2015-06-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −200 | 30 000 | −0,66 | 32,96 | −6 592 | 988 800 |
2015-06-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −1 300 | 30 200 | −4,13 | 32,37 | −42 081 | 977 574 |
2015-06-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 1 500 | 31 500 | 5,00 | 3,88 | 5 820 | 122 220 |
2015-06-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −100 | 30 000 | −0,33 | 32,97 | −3 297 | 989 100 |
2015-06-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −4 900 | 30 100 | −14,00 | 32,49 | −159 201 | 977 949 |
2015-06-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 5 000 | 35 000 | 16,67 | 3,88 | 19 400 | 135 800 |
2015-05-13 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | −5 000 | 72 251 | −6,47 | ||||
2015-05-13 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −6 500 | 77 251 | −7,76 | |||
2015-05-13 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | 5 000 | 30 000 | 20,00 | 3,88 | 19 400 | 116 400 | |
2015-05-13 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −1 500 | 25 000 | −5,66 | 31,78 | −47 670 | 794 500 |
2015-05-13 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −100 | 26 500 | −0,38 | 32,40 | −3 240 | 858 600 |
2015-05-13 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −4 900 | 26 600 | −15,56 | 31,79 | −155 771 | 845 614 |
2015-05-13 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 6 500 | 31 500 | 26,00 | 3,88 | 25 220 | 122 220 |
2015-04-08 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −5 000 | 83 751 | −5,63 | |||
2015-04-08 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −2 000 | 88 751 | −2,20 | |||
2015-04-08 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −500 | 25 000 | −1,96 | 35,50 | −17 750 | 887 500 |
2015-04-08 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −4 500 | 25 500 | −15,00 | 34,80 | −156 600 | 887 400 |
2015-04-08 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 5 000 | 30 000 | 20,00 | 3,88 | 19 400 | 116 400 |
2015-04-08 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −250 | 25 000 | −0,99 | 35,52 | −8 880 | 888 000 |
2015-04-08 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −1 750 | 25 250 | −6,48 | 34,82 | −60 935 | 879 205 |
2015-04-08 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 2 000 | 27 000 | 8,00 | 3,88 | 7 760 | 104 760 |
2015-03-24 |
|
4 | VCEL |
Vericel Corp
Stock Option (right to buy) |
A - Award | 20 000 | 20 000 | |||||
2015-03-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −1 500 | 90 751 | −1,63 | |||
2015-03-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −5 000 | 92 251 | −5,14 | |||
2015-03-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −200 | 25 000 | −0,79 | 40,94 | −8 188 | 1 023 500 |
2015-03-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −1 300 | 25 200 | −4,91 | 40,14 | −52 182 | 1 011 528 |
2015-03-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 1 500 | 26 500 | 6,00 | 3,88 | 5 820 | 102 820 |
2015-03-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −619 | 25 000 | −2,42 | 40,93 | −25 336 | 1 023 250 |
2015-03-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −4 381 | 25 619 | −14,60 | 40,16 | −175 941 | 1 028 859 |
2015-03-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 5 000 | 30 000 | 20,00 | 3,88 | 19 400 | 116 400 |
2015-02-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −1 500 | 97 251 | −1,52 | |||
2015-02-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −5 000 | 98 751 | −4,82 | |||
2015-02-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −1 500 | 25 000 | −5,66 | 36,65 | −54 975 | 916 250 |
2015-02-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 1 500 | 26 500 | 6,00 | 3,88 | 5 820 | 102 820 |
2015-02-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −400 | 25 000 | −1,57 | 37,11 | −14 844 | 927 750 |
2015-02-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −4 600 | 25 400 | −15,33 | 36,60 | −168 360 | 929 640 |
2015-02-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 5 000 | 30 000 | 20,00 | 3,88 | 19 400 | 116 400 |
2015-01-13 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −2 000 | 103 751 | −1,89 | |||
2015-01-13 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −845 | 25 000 | −3,27 | 41,04 | −34 679 | 1 026 000 |
2015-01-13 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −1 155 | 25 845 | −4,28 | 40,38 | −46 639 | 1 043 621 |
2015-01-13 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 2 000 | 27 000 | 8,00 | 3,88 | 7 760 | 104 760 |
2015-01-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
A - Award | 41 000 | 41 000 | |||||
2015-01-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −5 000 | 105 751 | −4,51 | |||
2015-01-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −4 300 | 25 000 | −14,68 | 39,59 | −170 237 | 989 750 |
2015-01-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −700 | 29 300 | −2,33 | 38,67 | −27 069 | 1 133 031 |
2015-01-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 5 000 | 30 000 | 20,00 | 3,88 | 19 400 | 116 400 |
2015-01-07 | 3 | VCEL |
Vericel Corp
No securities are beneficially owned |
0 | ||||||||
2014-12-19 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | −15 000 | 110 751 | −11,93 | ||||
2014-12-19 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | 15 000 | 25 000 | 150,00 | 3,88 | 58 200 | 97 000 | |
2014-12-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −10 000 | 125 751 | −7,37 | |||
2014-12-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −100 | 10 000 | −0,99 | 47,64 | −4 764 | 476 400 |
2014-12-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −200 | 10 100 | −1,94 | 46,76 | −9 352 | 472 276 |
2014-12-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −300 | 10 300 | −2,83 | 45,79 | −13 737 | 471 637 |
2014-12-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −1 600 | 10 600 | −13,11 | 44,84 | −71 744 | 475 304 |
2014-12-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −1 100 | 12 200 | −8,27 | 44,21 | −48 631 | 539 362 |
2014-12-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −1 300 | 13 300 | −8,90 | 42,86 | −55 718 | 570 038 |
2014-12-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −200 | 14 600 | −1,35 | 41,18 | −8 236 | 601 228 |
2014-12-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −200 | 14 800 | −1,33 | 39,52 | −7 904 | 584 896 |
2014-12-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −196 | 15 000 | −1,29 | 47,23 | −9 257 | 708 450 |
2014-12-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −300 | 15 196 | −1,94 | 46,39 | −13 917 | 704 942 |
2014-12-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −1 000 | 15 496 | −6,06 | 45,17 | −45 170 | 699 954 |
2014-12-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −1 759 | 16 496 | −9,64 | 44,34 | −77 994 | 731 433 |
2014-12-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −1 344 | 18 255 | −6,86 | 42,96 | −57 738 | 784 235 |
2014-12-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −100 | 19 599 | −0,51 | 41,14 | −4 114 | 806 303 |
2014-12-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −201 | 19 699 | −1,01 | 40,34 | −8 108 | 794 658 |
2014-12-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −100 | 19 900 | −0,50 | 38,52 | −3 852 | 766 548 |
2014-12-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 10 000 | 20 000 | 100,00 | 3,88 | 38 800 | 77 600 |
2014-11-14 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −10 000 | 135 751 | −6,86 | |||
2014-11-14 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −3 138 | 10 000 | −23,88 | 33,58 | −105 374 | 335 800 |
2014-11-14 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −1 862 | 13 138 | −12,41 | 32,39 | −60 310 | 425 540 |
2014-11-14 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −3 050 | 15 000 | −16,90 | 33,60 | −102 480 | 504 000 |
2014-11-14 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −1 950 | 18 050 | −9,75 | 32,44 | −63 258 | 585 542 |
2014-11-14 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 10 000 | 20 000 | 100,00 | 3,88 | 38 800 | 77 600 |
2014-10-27 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | −10 000 | 145 751 | −6,42 | ||||
2014-10-27 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | 10 000 | 10 000 | 3,88 | 38 800 | 38 800 | ||
2014-10-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −10 000 | 155 751 | −6,03 | |||
2014-10-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −10 000 | 0 | −100,00 | 29,25 | −292 500 | |
2014-10-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 10 000 | 10 000 | 3,88 | 38 800 | 38 800 | |
2014-09-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −6 700 | 165 751 | −3,89 | |||
2014-09-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −370 | 0 | −100,00 | 24,75 | −9 158 | |
2014-09-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −6 330 | 370 | −94,48 | 24,24 | −153 439 | 8 969 |
2014-09-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 6 700 | 6 700 | 3,88 | 25 996 | 25 996 | |
2014-09-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −3 300 | 172 451 | −1,88 | |||
2014-09-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −3 300 | 0 | −100,00 | 24,90 | −82 170 | |
2014-09-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 3 300 | 3 300 | 3,88 | 12 804 | 12 804 | |
2014-08-15 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −7 000 | 175 751 | −3,83 | |||
2014-08-15 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −3 000 | 182 751 | −1,62 | |||
2014-08-15 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −7 000 | 0 | −100,00 | 29,79 | −208 530 | |
2014-08-15 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 7 000 | 7 000 | 3,88 | 27 160 | 27 160 | |
2014-08-15 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −3 000 | 0 | −100,00 | 29,76 | −89 280 | |
2014-08-15 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 3 000 | 3 000 | 3,88 | 11 640 | 11 640 | |
2014-07-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −7 000 | 185 751 | −3,63 | |||
2014-07-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −3 000 | 192 751 | −1,53 | |||
2014-07-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −1 800 | 0 | −100,00 | 32,59 | −58 662 | |
2014-07-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −5 200 | 1 800 | −74,29 | 31,42 | −163 384 | 56 556 |
2014-07-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 7 000 | 7 000 | 3,88 | 27 160 | 27 160 | |
2014-07-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −800 | 0 | −100,00 | 32,56 | −26 048 | |
2014-07-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −2 200 | 800 | −73,33 | 31,40 | −69 080 | 25 120 |
2014-07-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 3 000 | 3 000 | 3,88 | 11 640 | 11 640 | |
2014-06-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to purchase Common Stock |
M - Exercise | X | −7 000 | 195 751 | −3,45 | |||
2014-06-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to purchase Common Stock |
M - Exercise | X | −3 000 | 202 751 | −1,46 | |||
2014-06-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −4 197 | 0 | −100,00 | 31,98 | −134 220 | |
2014-06-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −2 803 | 4 197 | −40,04 | 31,16 | −87 341 | 130 779 |
2014-06-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 7 000 | 7 000 | 3,88 | 27 160 | 27 160 | |
2014-06-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −1 686 | 0 | −100,00 | 32,00 | −53 952 | |
2014-06-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −1 314 | 1 686 | −43,80 | 31,17 | −40 957 | 52 553 |
2014-06-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 3 000 | 3 000 | 3,88 | 11 640 | 11 640 | |
2014-05-21 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −7 000 | 205 751 | −3,29 | |||
2014-05-21 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −3 000 | 212 751 | −1,39 | |||
2014-05-21 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −286 | 0 | −100,00 | 32,17 | −9 201 | |
2014-05-21 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −6 714 | 286 | −95,91 | 31,49 | −211 424 | 9 006 |
2014-05-21 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 7 000 | 7 000 | 3,88 | 27 160 | 27 160 | |
2014-05-21 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −100 | 0 | −100,00 | 32,27 | −3 227 | |
2014-05-21 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −2 900 | 100 | −96,67 | 31,48 | −91 292 | 3 148 |
2014-05-21 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 3 000 | 3 000 | 3,88 | 11 640 | 11 640 | |
2013-12-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
A - Award | 29 000 | 29 000 |